Intervention and medicinal approaches to the management of patients with heart rhythm problems.International medical conference
Date: Maggio 16-17
Online registration is required.No admission without registration confirmation.
Argomenti principali:
Sick Sinus Syndrome • Electrophysiological Substrate • Natural History • Update in Prognosis and Treatment Atrial Fibrillation • Epidemiology and Social Burden • Classification • Anatomical and Electrical Changes • Prognosis • Pharmacological and Non-Pharmacological Treatment • Non Antiarrhythmic Drugs to Prevent Atrial Fibrillation Recurrences • Cost-Benefit of The Various Therapeutical Strategies • Equal Access to Therapy for All The Patients • External, Esophageal, Internal Cardioversion • Permanent Anticoagulation New and Old Drugs • Percutaneous Closure of The Left Atrial Appendage • Post CABG Atrial Fibrillation Prevention and Treatment • Non-Antiarrhythmic Drugs for AF Prevention • Stroke Prevention by AF Early Detection • Transtelephonic Remote Control • Disease Management and Comorbidities AV and Intraventricular Conduction Disturbances • In The Acute Myocardial Infarction Setting • Progression and Prognosis • Hemodynamic Imbalance • Echocardiographic Evaluation • Appropriate Device Implantation and Programming • Temporary Pacing During Non Cardiac Surgery Sudden Death • Epidemiology and Classification • Underlying Heart Disease • Prevention • Identification of Candidates and of The Most Appropriate Treatment • Cost-Benefit • Equal Access to Therapy for All The Patients • Automatic External Defibrillation: Devices, Training Programs, Cost-Benefit Non Invasive Sudden Death Risk Stratification • QT Dynamicity • T Wave Alternans • Heart Rate Variability and Turbulence • Baroreflex Sensitivity • QRS Width Heart Failure • Atrial Fibrillation • Malignant Ventricular Tachyarrhythmias • Inter and Intraventricular Dissinchrony • AV Nodal Conduction Troubles • Supraventricular and Ventricular Repetitive Ectopic Beats • Echocardiographic Evaluation • Cardiac Revascolarization Benefits • Emerging Role of the Heart Failure/Device Specialists Genetic Arrhythmias • Brugada Syndrome • Arrhythmogenic Right Ventricular Dysplasia • Long QT Syndrome • Short QT Syndrome • Cathecolaminergic Ventricular Tachycardia Hypertrophic Cardiomiopathy • Identification of Candidates to Sudden Death • Various Therapeutical Strategies (Pacing, ICD, Alchoolization) Arrhythmias in Diabetic Patients Pediatric Arrhythmias • Clinical Issues • Electrophysiology and Pacing in Pediatric Patients Sleep Apnea Cardiac Syncope • Neuromediated-Orthostatic • In Patients with Structural Heart Disease • In Patients with Genetic Disease • Diagnostic Flow-Chart • Pharmacological Treatment • Indications to Permanent Pacing • Special Pacing Algorithms • Implantable Diagnostic Tools • Body Posture and Drugs Influence • Prognostic Signifi cance • Data from Registries and Trials Echocardiography in Arrhythmology • Identifi cation of Atrial Thrombo-Embolic Sources • Evaluation of Intraventricular and Interventricular Delay • Selection of Coronary Sinus Lead Appropriate Site in CRT • Optimal AV Interval Programming in DDD Pacing • Optimal VV Timing in CRT • Patient Risk Stratifi cation Post Myocardial Infarction • Indications to Lead Extraction • Intraprocedure Cardiac Tamponade • Intracardiac Echocardiography Arrhythmias in Athletes • Prognostic Signifi cance • Eligibility for Competitive Sports • Selection of the Most Appropriate Sport Activity • Diagnostic and Therapeutic Flow-Chart • Sport Practice in Pacemaker and ICD Patients
Invito a presentare abstract di poster:
Appuntamenti importanti
Il Comitato del Programma Scientifico ti invita a presentare la tua ricerca sotto forma di un abstract di una pagina (2500 caratteri) . Accogliamo con favore proposte basate sulla ricerca accademica . Saranno benvenuti anche gli abstract dei casi di studio.
Gli abstract dovranno includere materiale e dati inediti. Non sarà accettato materiale formalmente pubblicato entro le date di invio degli abstract. La maggior parte degli abstract senza dati a supporto dei risultati verranno rifiutati. Tuttavia, abstract che descrivono la progettazione dello studio e i metodi per studi ben sviluppati e/o finanziati (cioè., nessun abstract per studi pilota o preliminari) può essere preso in considerazione per la presentazione di poster a seconda della qualità dell'astratto.
Tutti gli abstract saranno sottoposti a peer review in forma anonima, valutato e scelto in base al merito per la presentazione del poster.
Le persone il cui abstract sarà selezionato dovranno registrarsi all'incontro; Non saranno accettati abstract di autori che non si registrano.
Condizioni di partecipazione per i partecipanti:
Pacchetto di registrazione include ,partecipazione alla sessione scientificaS, materiali del convegno, visita alla mostra e 10-30% sconto per il pernottamento in albergo.
